CellWell record HH-480745
Effect of Dapagliflozin on Albuminuria and HbA1c in Diabetic Patients in Dubai: A Real-World Study
Sajitha Prasad; P. S. Prasad; Sangeeta Sharma; A. Saba; Afra Ahli; Adil Maqbool; Hanan Abdalla Hamza
Saudi Journal of Medicine ยท 2026
In plain language
In 200 adults with type 2 diabetes in Dubai primary care, starting a new glucose-lowering drug was associated with a 57.7% fall in urine albumin and HbA1c dropping from 8.2% to 6.8% over 24 months.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-480745
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.